Navigation Links
UF gets almost $15 million in federal funds to build research complex to help older adults
Date:1/19/2010

opment at UF and around the region.

"Thanks to Dr. Pahor and his team, we now will have a centerpiece around which we can potentially develop more broadly an academic home for clinical and translational science at UF," said David Guzick, M.D., Ph.D., senior vice president for health affairs and president of the UF&Shands Health System.

Bringing researchers from varied fields such as genetics and biostatistics under the same roof will facilitate the kinds of spontaneous and informal interaction that often lead to meaningful multidisciplinary collaborations. The building also will allow clinical investigators better supervision of field operations.

Awarded through a highly competitive peer-review process, the construction grant will be administered by the National Center for Research Resources, the same agency that last year awarded UF a Clinical and Translational Science Award.

Funded under the American Recovery and Reinvestment Act of 2009, the project will create or retain an estimated 376 jobs, three quarters of which will be construction-related. The others include 30 faculty positions as well as graduate assistants and support and administrative staff.

The new grant comes on the heels of a recent $64 million NIH research award to the UF Institute on Aging to study whether physical activity can help prevent mobility disability and other morbidities in older adults.

Together the institute's researchers have more than 90 active NIH and other grants in basic, clinical and translational science totaling more than $200 million, and almost 150 pending grant proposals that would garner close to $200 million if funded. The new building helps to pull all those scientific efforts together and improve the possibility for even greater impact of the Institute on Aging.

"The Institute on Aging initiative at the University of Florida is very important to the state and the nation," said Win Phillips, D.Sc., UF's vice
'/>"/>

Contact: Czerne M. Reid
czerne@ufl.edu
352-273-5814
University of Florida
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. SinuNase Phase 3 show almost 100 percent of chronic sinusitis cases are from fungal-induced inflamma
2. Genetics reveals big fish that almost got away
3. Almost 7 million pregnant in sub-Saharan Africa infected with hookworms; at risk of anaemia
4. Muscular dystrophy diagnosis delayed almost 2.5 years in boys
5. McGill University receives almost $63 million under CFI program to support five research projects
6. Structure of 450 million year old protein reveals evolutions steps
7. First orchid fossil puts showy blooms at some 80 million years old
8. SyntheMed Completes $2.8 Million Equity Financing
9. Rutgers Genetics receives $7.8 million for autism research
10. Seattle Childrens Hospital leads $23.7 million NIH grant to study gene repair
11. UD leads $5.3-million research project on rice epigenetics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2014)... 2014  Tute Genomics, a leader in cloud-based solutions ... A1 funding led by UK-based Eurovestech. Peak Ventures and ... investment round. "We are at a pivotal ... sequencing and seeks new approaches for the diagnosis, treatment ... MD MBA, and CEO of Tute Genomics. "One of ...
(Date:11/21/2014)... , Nov. 19, 2014  Earlier this year ... New York College, and one of the most prolific ... signals that are transmitted from Smartphones to third party ... Smartphones and has one of the earliest known patents ... its usage in the military, child care, elder care ...
(Date:11/18/2014)... 2014   News Highlights: ... develop The Partners Data Lake, an agile data ... Lake will allow researcher and clinicians to explore ... the lives of patients , The Partners ... across the Partners system, breaking down physical barriers ...
Breaking Biology News(10 mins):Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 2Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 2Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 3Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 5
... is perhaps impossible to overstate the importance of the tumor ... gene in human tumors. p53 keeps pre-cancerous cells in check ... aging at the cellular level. Loss of p53 causes cells ... or damaged cells die or stop growing. In ...
... This press release is available in Spanish . ... U.S. Department of Agriculture (USDA) scientists are learning more ... fieldsand whether they,ll actively feed on crop pests. ... the North Central Agricultural Research Laboratory in Brookings, S.D., ...
... in sustained tissue damage in the brains and spines of ... reveal. Cytoxic T cells, also known as CD8+ T ... body,s arsenal to fight disease. Multiple sclerosis is characterized ... and destroy the axons, electrical impulse conductors that look like ...
Cached Biology News:Cancer suppressor gene links metabolism with cellular aging 2Cancer suppressor gene links metabolism with cellular aging 3Lady beetle diet influences its effectiveness as biocontrol agent 2Multiple sclerosis study reveals how killer T cells learn to recognize nerve fiber insulators 2Multiple sclerosis study reveals how killer T cells learn to recognize nerve fiber insulators 3Multiple sclerosis study reveals how killer T cells learn to recognize nerve fiber insulators 4
(Date:12/15/2014)... METTLER TOLEDO is pleased to announce that the ... PVM technology , is now available. The new ... continuously captures high-resolution images under a wide range ... a report pairing the most relevant images to ... compelling blend of high resolution images and trend ...
(Date:12/15/2014)... COPENHAGEN, Denmark , Dec. 15, 2014 /PRNewswire/ ... its innovative TransCon technology to address significant unmet ... from its ongoing Phase 2 pediatric study to ... growth hormone deficiency, or GHD.  This interim analysis ... the anticipated total enrollment in the study, completing ...
(Date:12/13/2014)... Washington, USA, and TAICHUNG, Taiwan (PRWEB) December 12, 2014 ... rise, despite less rosy indicators in overall global economic ... society for optics and photonics , said in a ... International Conference) on 5 December at the National Chung ... solar energy, which is being integrated into future energy ...
(Date:12/13/2014)... DUBLIN , Dec. 11, 2014 Research ... announced the addition of the "Glucose Sensors: ... http://photos.prnewswire.com/prnh/20130307/600769 ... biocompatible product designs is giving hope for a ... Noninvasive glucose monitors that can measure glucose levels ...
Breaking Biology Technology:New Real-Time In Situ Probe-Based Video Microscope from METTLER TOLEDO 2Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Photonics Continues Upward Trends Despite Challenges in the Global Economy, Notes SPIE CEO 2Photonics Continues Upward Trends Despite Challenges in the Global Economy, Notes SPIE CEO 3Photonics Continues Upward Trends Despite Challenges in the Global Economy, Notes SPIE CEO 4Photonics Continues Upward Trends Despite Challenges in the Global Economy, Notes SPIE CEO 5Glucose Sensors: the Next Generation 2Glucose Sensors: the Next Generation 3
... create the largest non-state-owned producers of ... plasma-based product in China, ... Inc. (OTC Bulletin Board: CBPO) ("China Biologic" or the,"Company"), one ... China ("PRC"), today announced that on September 26,2008, the Company ...
... LIVINGSTON, N.J., Oct. 2 Milestone Scientific,Inc. ... in advanced,injection technologies, today announced that it ... painless anesthetic injections --,specifically rights related to ... providing these injections -- through issuance of ...
... Radioimmunotherapy in U.S. to be Indicated ... for Use in First-Line ... and MTA: CTIC) announced today that it has submitted a ... (FDA) for use of Zevalin(R) ([90Y]-ibritumomab tiuxetan) as,consolidation therapy after ...
Cached Biology Technology:China Biologic Products Enters Into Agreement to Acquire 90% Controlling Interest in Chongqing Dalin Biologic Technologies Co., Ltd. 2China Biologic Products Enters Into Agreement to Acquire 90% Controlling Interest in Chongqing Dalin Biologic Technologies Co., Ltd. 3China Biologic Products Enters Into Agreement to Acquire 90% Controlling Interest in Chongqing Dalin Biologic Technologies Co., Ltd. 4China Biologic Products Enters Into Agreement to Acquire 90% Controlling Interest in Chongqing Dalin Biologic Technologies Co., Ltd. 5Milestone Scientific Acquires Additional Patent Rights for Painless Injections and Resolves Related Litigations 2Milestone Scientific Acquires Additional Patent Rights for Painless Injections and Resolves Related Litigations 3Cell Therapeutics Submits Supplemental Biologics License Application for Zevalin Use in First-Line Consolidation Therapy 2Cell Therapeutics Submits Supplemental Biologics License Application for Zevalin Use in First-Line Consolidation Therapy 3Cell Therapeutics Submits Supplemental Biologics License Application for Zevalin Use in First-Line Consolidation Therapy 4Cell Therapeutics Submits Supplemental Biologics License Application for Zevalin Use in First-Line Consolidation Therapy 5
, Premium quality synthesis and purification , You provide the sequence, we'll do the rest , Rigorous quality control , Your choice of purification method, amount and format , Available annealed...
... Ambion's custom siRNA service provides the ... gene silencing research. Custom siRNAs can be ... 19-21 base target sequence, or by providing ... check out Ambion's Silencer Validated ...
... Ambion's custom siRNA service provides the ... gene silencing research. Custom siRNAs can be ... 19-21 base target sequence, or by providing ... check out Ambion's Silencer Validated and Silencer ...
Human TGF-beta RIIb Affinity Purified Polyclonal Ab...
Biology Products: